H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 53 Citations 16,164 117 World Ranking 2444 National Ranking 97

Research.com Recognitions

Awards & Achievements

2018 - Member of Academia Europaea

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Asthma
  • Disease

Elisabeth H. Bel focuses on Asthma, Immunology, Internal medicine, Exhaled nitric oxide and Physical therapy. Her study in Asthma focuses on Anti-asthmatic Agent in particular. The various areas that she examines in her Immunology study include Airway obstruction, Airway, Sputum Cytology and Cohort.

Her Internal medicine research also works with subjects such as

  • Gastroenterology, which have a strong connection to Eosinophilia and Reslizumab,
  • Surgery, which have a strong connection to Family medicine. Her study in Exhaled nitric oxide is interdisciplinary in nature, drawing from both Eosinophil, Placebo-controlled study and Pathology. Her Physical therapy research includes themes of Refractory asthma and Intensive care medicine.

Her most cited work include:

  • International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma (1799 citations)
  • Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma (815 citations)
  • Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. (422 citations)

What are the main themes of her work throughout her whole career to date?

Elisabeth H. Bel spends much of her time researching Asthma, Internal medicine, Immunology, Intensive care medicine and COPD. She has researched Asthma in several fields, including Physical therapy, Disease and Pediatrics. Her work on Mepolizumab, Corticosteroid and Cohort as part of general Internal medicine research is often related to In patient, thus linking different fields of science.

Her Immunology research is multidisciplinary, relying on both Fibrinolysis, Airway and Eosinophilic. Her studies deal with areas such as Pulmonary disease, Severity of illness and Respiratory system as well as Intensive care medicine. Elisabeth H. Bel interconnects Observational study and Asthma Control Questionnaire in the investigation of issues within COPD.

She most often published in these fields:

  • Asthma (68.62%)
  • Internal medicine (41.84%)
  • Immunology (29.29%)

What were the highlights of her more recent work (between 2017-2021)?

  • Asthma (68.62%)
  • Internal medicine (41.84%)
  • Mepolizumab (10.04%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Asthma, Internal medicine, Mepolizumab, Severe asthma and COPD. Her Asthma research entails a greater understanding of Immunology. Her Internal medicine study deals with Gastroenterology intersecting with Nasal polyps, Exhaled nitric oxide and Peripheral blood.

In her work, Long term safety is strongly intertwined with Eosinophilic asthma, which is a subfield of Mepolizumab. She combines subjects such as Airway inflammation, Clinical research, Randomized controlled trial and Asthma Control Questionnaire with her study of Severe asthma. Her research in the fields of Obstructive lung disease overlaps with other disciplines such as Novelty.

Between 2017 and 2021, her most popular works were:

  • Pathway discovery using transcriptomic profiles in adult-onset severe asthma (59 citations)
  • Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology (49 citations)
  • Predictors of accelerated decline in lung function in adult-onset asthma (30 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Asthma
  • Disease

Elisabeth H. Bel spends much of her time researching Asthma, Internal medicine, Immunology, Intensive care medicine and Exacerbation. She studies Exhaled nitric oxide which is a part of Asthma. Her research links Gastroenterology with Internal medicine.

Her research investigates the connection with Intensive care medicine and areas like COPD which intersect with concerns in Disease burden. As a part of the same scientific study, she usually deals with the Exacerbation, concentrating on Emergency department and frequently concerns with Single-nucleotide polymorphism. In her study, Prednisone is strongly linked to Placebo, which falls under the umbrella field of Benralizumab.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly.
The Journal of Allergy and Clinical Immunology (2012)

7730 Citations

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Kian Fan Chung;Sally E. Wenzel;Jan L. Brozek;Andrew Bush.
European Respiratory Journal (2014)

2805 Citations

Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

Elisabeth H. Bel;Sally E. Wenzel;Philip J. Thompson;Charlene M. Prazma.
The New England Journal of Medicine (2014)

1134 Citations

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.

David Cheung;Mieke C. Timmers;Aeilko H. Zwinderman;Elisabeth H. Bel.
The New England Journal of Medicine (1992)

651 Citations

Treatable traits: toward precision medicine of chronic airway diseases.

Alvar Agusti;Elisabeth Bel;Mike Thomas;Claus Vogelmeier.
European Respiratory Journal (2016)

565 Citations

Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society

KF Chung;P Godard;E Adelroth;J Ayres.
European Respiratory Journal (1999)

525 Citations

An electronic nose in the discrimination of patients with asthma and controls

Silvano Dragonieri;Robert Schot;Bart J.A. Mertens;Saskia Le Cessie.
The Journal of Allergy and Clinical Immunology (2007)

470 Citations

Factors associated with persistent airflow limitation in severe asthma.

Anneke ten Brinke;Aeilko H. Zwinderman;Peter J. Sterk;Klaus F. Rabe.
American Journal of Respiratory and Critical Care Medicine (2001)

437 Citations

After asthma: redefining airways diseases

Ian D Pavord;Richard Beasley;Alvar Agusti;Gary P Anderson.
The Lancet (2017)

413 Citations

The prevalence of severe refractory asthma

Pieter-Paul W. Hekking;Reinier R. Wener;Marijke Amelink;Aelko H. Zwinderman.
The Journal of Allergy and Clinical Immunology (2015)

400 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Elisabeth H. Bel

Peter G. Gibson

Peter G. Gibson

University of Newcastle Australia

Publications: 149

Kian Fan Chung

Kian Fan Chung

National Institutes of Health

Publications: 146

Sally E. Wenzel

Sally E. Wenzel

University of Pittsburgh

Publications: 118

Peter J. Sterk

Peter J. Sterk

University of Amsterdam

Publications: 118

Ian D. Pavord

Ian D. Pavord

University of Oxford

Publications: 114

Jean Bousquet

Jean Bousquet

Inserm : Institut national de la santé et de la recherche médicale

Publications: 112

Andrew Bush

Andrew Bush

National Institutes of Health

Publications: 108

Christopher E. Brightling

Christopher E. Brightling

University of Leicester

Publications: 98

Giorgio Walter Canonica

Giorgio Walter Canonica

Humanitas University

Publications: 96

Ian M. Adcock

Ian M. Adcock

National Institutes of Health

Publications: 91

Claus Bachert

Claus Bachert

Ghent University

Publications: 86

Pascal Chanez

Pascal Chanez

Aix-Marseille University

Publications: 84

Peter J. Barnes

Peter J. Barnes

Imperial College London

Publications: 80

Mario Castro

Mario Castro

University of Kansas

Publications: 77

Ratko Djukanovic

Ratko Djukanovic

University of Southampton

Publications: 76

Eugene R. Bleecker

Eugene R. Bleecker

University of Arizona

Publications: 75

Something went wrong. Please try again later.